Elevated neuropeptide levels decrease during liver transplant.
D'Souza
M
M
Mayo Clinic and Foundation, Rochester, Minnesota 55905.
Plevak
D
D
Kvols
L
L
Shine
T
T
Stapelfeldt
W
W
Nelson
D
D
Southorn
P
P
Murray
M
M
D000704:Analysis of Variance; D015740:Calcitonin Gene-Related Peptide / Q000097:blood; D006801:Humans; D008107:Liver Diseases / Q000097:blood / Q000601:surgery; D016031:Liver Transplantation / Q000502:physiology*; D009478:Neuropeptide Y / Q000097:blood; D009479:Neuropeptides / Q000097:blood*; D010451:Peptide PHI / Q000097:blood; D019894:Peptide YY; D010455:Peptides / Q000097:blood; D013373:Substance P / Q000097:blood; D013997:Time Factors; D014660:Vasoactive Intestinal Peptide / Q000097:blood
D009478:Neuropeptide Y; D009479:Neuropeptides; D010451:Peptide PHI; D010455:Peptides; D019894:Peptide YY; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D015740:Calcitonin Gene-Related Peptide